FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 3201. Misbranding of procaine hydrochloride 2% and adulteration and misbranding of Salicyline No. 2 tablets. U. S. v. C. B. Kendall Co., Inc., Claude B. Kendall, and Ralph E. Monteith. Pleas of nolo contendere. Fines of $1,800 against corporation, $1,800 against defendant Monteith, and $900 against defendant Kendall. ✖Remove constraint Titles: 3201. Misbranding of procaine hydrochloride 2% and adulteration and misbranding of Salicyline No. 2 tablets. U. S. v. C. B. Kendall Co., Inc., Claude B. Kendall, and Ralph E. Monteith. Pleas of nolo contendere. Fines of $1,800 against corporation, $1,800 against defendant Monteith, and $900 against defendant Kendall. Defendants C. B. Kendall Co., Inc., Indianapolis, Ind., Claude B. Kendall, president of the corporation, and Ralph E. Monteith, chief chemist for the corporation. ✖Remove constraint Defendants: C. B. Kendall Co., Inc., Indianapolis, Ind., Claude B. Kendall, president of the corporation, and Ralph E. Monteith, chief chemist for the corporation. Issue Dates January 1951 ✖Remove constraint Issue Dates: January 1951

Refine by:

  • 3201. Misbranding of procaine hydrochloride 2% and adulteration and misbranding of Salicyline No. 2 tablets. U. S. v. C. B. Kendall Co., Inc., Claude B. Kendall, and Ralph E. Monteith. Pleas of nolo contendere. Fines of $1,800 against corporation, $1,800 against defendant Monteith, and $900 against defendant Kendall.1

  • C. B. Kendall Co., Inc., Indianapolis, Ind., Claude B. Kendall, president of the corporation, and Ralph E. Monteith, chief chemist for the corporation.1